BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA was reported 81 times

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD123 Interaction [EPC] 10 0.0186
1 CD38-directed Cytolytic Antibody [EPC] 4 0.0007
2 BCL-2 Inhibitor [EPC] 23 0.0004
3 Cannabinoid [EPC] 1 0.0001
4 Topoisomerase Inhibitor [EPC] 9 0.0001
5 Nucleoside Metabolic Inhibitor [EPC] 31 0.0001
6 Alkylating Drug [EPC] 19 0.0001
7 Proteasome Inhibitor [EPC] 8 0.0001
8 Azole Antifungal [EPC] 7 0.0000
9 Erythropoiesis-stimulating Agent [EPC] 2 0.0000
10 Microtubule Inhibitor [EPC] 6 0.0000
11 Complement Inhibitor [EPC] 2 0.0000
12 Iron Chelator [EPC] 1 0.0000
13 Xanthine Oxidase Inhibitor [EPC] 5 0.0000
14 Platinum-based Drug [EPC] 7 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 11 0.0000
16 Leukocyte Growth Factor [EPC] 3 0.0000
17 Purine Antimetabolite [EPC] 2 0.0000
18 Corticosteroid [EPC] 20 0.0000
19 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
20 Kinase Inhibitor [EPC] 5 0.0000
21 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
22 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
23 Thalidomide Analog [EPC] 4 0.0000
24 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
25 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
26 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
27 Loop Diuretic [EPC] 2 0.0000
28 Proton Pump Inhibitor [EPC] 2 0.0000
29 Vitamin D [EPC] 1 0.0000
30 Vitamin B12 [EPC] 1 0.0000
31 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
32 Vitamin C [EPC] 1 0.0000
33 Atypical Antipsychotic [EPC] 1 0.0000
34 Benzodiazepine [EPC] 1 0.0000
35 Tumor Necrosis Factor Blocker [EPC] 1 0.0000